4.7 Editorial Material

On the Proposed Definition of Metabolic-Associated Fatty Liver Disease

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Redefining fatty liver disease: an international patient perspective

Gamal Shiha et al.

Summary: The article discusses the renaming of non-alcoholic fatty liver disease to metabolic-associated fatty liver disease, with patient advocacy groups enthusiastically supporting this change. They believe it will have a positive impact on patient care, quality of life, and reduce burdens on healthcare systems.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease

Nahum Mendez-Sanchez et al.

Summary: The Latin American Association for the Study of the Liver aims to promote liver health and quality patient care, with a recent focus on fatty liver disease associated with metabolic dysfunction. A consensus was reached to rename the disease as metabolic-associated fatty liver disease and to diagnose it using a set of simple criteria. This change is expected to improve disease awareness and advancements in various aspects of the disease.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Epidemiology of chronic liver diseases in the USA in the past three decades

Zobair M. Younossi et al.

Article Gastroenterology & Hepatology

A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe

Jeffrey Lazarus et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Comparison of MAFLD and NAFLD diagnostic criteria in real world

Su Lin et al.

LIVER INTERNATIONAL (2020)

Editorial Material Gastroenterology & Hepatology

The times they are a-changin' (for NAFLD as well)

Vlad Ratziu et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

Sakura Yamamura et al.

LIVER INTERNATIONAL (2020)

Article Gastroenterology & Hepatology

Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease

Zobair M. Younossi et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Article Medicine, General & Internal

Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease

David E. Kleiner et al.

JAMA NETWORK OPEN (2019)

Review Gastroenterology & Hepatology

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Zobair Younossi et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Editorial Material Public, Environmental & Occupational Health

What's in a name? A call to reframe non-communicable diseases

Luke N. Allen et al.

LANCET GLOBAL HEALTH (2017)

Review Gastroenterology & Hepatology

Pathogenesis and novel treatment options for non-alcoholic steatohepatitis

Vincent Wai-Sun Wong et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies

Siddharth Singh et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)

Article Medicine, General & Internal

Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists

C. -J. Bergqvist et al.

INTERNAL MEDICINE JOURNAL (2013)

Article Gastroenterology & Hepatology

Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma

Yusuke Kawamura et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)